John Ballantyne

CIK: 0001701346

Transaction Breakdown

Open Market Buys (P)3 (37.5%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (37.5%)

Compensation grants

Other (G, F, J, C, D, …)2 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

GCTK

Glucotrack, Inc.

Director10% Owner

Discretionary Trading P&L

Holdings

Transaction History (8 total)

GCTK
Glucotrack, Inc.
Mar 26, 2025
Award(A)
Direct
4.1K shares-
GCTK
Glucotrack, Inc.
Mar 12, 2025
In-the-Money(X)
Indirect
2.6M shares-
GCTK
Glucotrack, Inc.
Nov 14, 2024
Other(J)
Indirect
132K shares at avg. $31.00$4.1M
GCTK
Glucotrack, Inc.
Nov 14, 2024
Award(A)
Series A Common Warrant
Indirect
132K shares-
GCTK
Glucotrack, Inc.
Nov 14, 2024
Award(A)
Series B Common Warrant
Indirect
132K shares-
GCTK
Glucotrack, Inc.
Jul 30, 2024
Purchase(P)
Warrants to Purchase Common Stock
Indirect
59.3K shares-
GCTK
Glucotrack, Inc.
Jul 30, 2024
Purchase(P)
Warrants to Purchase Common Stock
Indirect
106.7K shares-
GCTK
Glucotrack, Inc.
Jul 30, 2024
Purchase(P)
Warrants to Purchase Common Stock
Indirect
76.2K shares-

		Type	Shares	Price		Ownership
Mar 26, 2025	GCTK Glucotrack, Inc.	Award(A)	4,126	-	-	Direct
Mar 12, 2025	GCTK Glucotrack, Inc.	In-the-Money(X)	2,560,553	-	-	Indirect
Nov 14, 2024	GCTK Glucotrack, Inc.	Other(J)	132,036	$31.00	$4,093,116	Indirect
Nov 14, 2024	GCTK Glucotrack, Inc.	Award(A) Series A Common Warrant	132,036	-	-	Indirect
Nov 14, 2024	GCTK Glucotrack, Inc.	Award(A) Series B Common Warrant	132,036	-	-	Indirect
Jul 30, 2024	GCTK Glucotrack, Inc.	Purchase(P) Warrants to Purchase Common Stock	59,260	-	-	Indirect
Jul 30, 2024	GCTK Glucotrack, Inc.	Purchase(P) Warrants to Purchase Common Stock	106,667	-	-	Indirect
Jul 30, 2024	GCTK Glucotrack, Inc.	Purchase(P) Warrants to Purchase Common Stock	76,191	-	-	Indirect

1-8 of 8 transactions

About BALLANTYNE JOHN

BALLANTYNE JOHN (SEC CIK 0001701346) files insider reports with the SEC as Director of Glucotrack, Inc. (GCTK).

Signal8 holds 2 ownership filings by BALLANTYNE JOHN (1 Form 3, 1 Form 4), filed between Nov 22, 2024 and Mar 31, 2025. Those filings report 8 transactions, from Jul 30, 2024 to Mar 26, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on BALLANTYNE JOHN's filings is in RUTHERFORD, NJ.

Recent filings by BALLANTYNE JOHN

Mar 26, 2025: Grant or award of GCTK shares (Form 4, code A).
Mar 12, 2025: Option exercise of GCTK shares (Form 4, code X).
Nov 14, 2024: Other transaction of GCTK shares (Form 4, code J).
Nov 14, 2024: Grants or awards of GCTK derivative securities (2 lines, Form 4, code A).
Jul 30, 2024: Open-market purchases of GCTK derivative securities (3 lines, Form 4, code P).

Other insiders filing for Glucotrack, Inc. (GCTK)

CARR BRENDEL VICTORIA, Director
Balo Andrew K, Director
Malave Luis, Director
Carter Erin Catherine, Director
Goode Paul, Chief Executive Officer
John A. Ballantyne Revocable Living Trust dated 08/01/2017, 10% Owner

How to read Form 4 transaction codes